India to Turkmenistan: Guaifenesin Export Trade Route
India has recorded 21 verified shipments of Guaifenesin exported to Turkmenistan, representing a combined trade value of $410.7K USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $19.6K USD. The leading Indian exporter is ACIES PHARMACEUTICAL PRIVATE LIMITED, which accounts for 33% of total export value with 9 shipments worth $135.4K USD. On the buying side, INDIVIDUAL ENTERPRISE ENEM is the largest importer in Turkmenistan with $86.8K USD in purchases. The top 3 suppliers — ACIES PHARMACEUTICAL PRIVATE LIMITED, AKRANO LIFE SCIENCES PRIVATE LIMITED , JMBS HEALTHCARE — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Turkmenistan Guaifenesin corridor is one of India's established pharmaceutical export routes, with 21 shipments documented worth a combined $410.7K USD. The route is dominated by ACIES PHARMACEUTICAL PRIVATE LIMITED, which alone accounts for roughly 33% of all export value, reflecting the consolidated nature of India's guaifenesin manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $19.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with guaifenesin's non-urgent bulk-order profile.
Shipment activity peaks during July-September, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 5%, placing it at rank #15 among India's top guaifenesin export destinations globally.
On the import side, key buyers of Indian guaifenesin in Turkmenistan include INDIVIDUAL ENTERPRISE ENEM , AKRAP FARMSEYL IE, ASIA TIR INTERNATIONAL and 9 others. INDIVIDUAL ENTERPRISE ENEM is the single largest importer with 2 shipments valued at $86.8K USD.
